slides · global inventory
Expose Contradiction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 14,162
Current window 9,451-9,480
Pages 473
Rows per page 30
Slide function
9,451-9,480 of 14,162
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
314
The slide uses red boxes and text annotations to highlight specific data points in the charts that contradict expected clinical outcomes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
316
The slide uses a 'villain' narrative by comparing Harmony's practices to the Insys case and official government fraud alerts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
317
The slide uses highlighted text to emphasize key admissions of quid pro quo arrangements.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
318
The slide uses direct quotes to expose potential unethical sales practices and reliance on key opinion leaders (KOLs) in the pharmaceutical industry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
319
The slide uses a Q&A format to validate the thesis of extreme concentration in prescribing behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
320
The slide uses highlighted text to emphasize key admissions regarding prescription volume and the criminal nature of the speaker program.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
321
The slide uses a Q&A format to highlight the 'quid pro quo' nature of the speaker programs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
322
The slide presents a Q&A transcript excerpt highlighting a potential compliance issue regarding speaker programs and prescription volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
323
The slide uses highlighted text to emphasize key admissions of fraud/inducement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
324
The slide uses a '>' character as a bullet point/indicator for the thesis statement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
325
The slide uses a 'fraud-exposure' narrative by contrasting the official label with market reality.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
326
The slide uses direct quotes from former territory managers to substantiate allegations of fraudulent marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses a Q&A transcript format to expose potentially fraudulent sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
328
The slide uses highlighted text to emphasize key allegations regarding pressure and compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
329
The slide uses a Q&A format to document unethical sales practices, specifically the verbal instruction to expand diagnoses to meet off-label sales goals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
330
Includes a Q&A transcript excerpt highlighting the 'buddy' system used to submit fake referrals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
331
The slide uses a Q&A format to highlight discrepancies in prescription volumes across similar-sized territories.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
332
The slide uses a Q&A format to present whistleblower testimony regarding unethical sales practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
333
The slide uses direct quotes to expose potential unethical or illegal marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
334
The slide uses direct quotes from former territory managers to establish the 'unusual' nature of the compensation plan.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
335
The slide uses direct quotes from two different ex-Harmony territory managers to build a case of systemic non-compliance and arbitrary quota setting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
336
The slide uses a Q&A transcript format to highlight the 'weird' nature of the compensation process at Harmony.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
337
The slide uses a Q&A transcript format to highlight alleged unethical practices and lack of transparency in sales compensation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
338
Includes direct Q&A transcript excerpts highlighting the alleged lack of transparency and short-term focus.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
339
The slide uses direct quotes to highlight operational inefficiencies and potential lack of transparency in the patient services process.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight the discrepancy between industry standards and Harmony's practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
341
The slide uses highlighted text to emphasize key phrases from expert interviews.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
342
The slide uses a Q&A format to build a case for regulatory or ethical misconduct.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit